Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1962 1
1968 1
1969 1
1973 2
1975 1
1976 3
1977 1
1978 1
1979 1
1982 1
1984 1
1985 1
1986 4
1991 2
1997 7
2000 1
2001 1
2002 1
2003 4
2004 4
2005 1
2006 2
2007 8
2008 4
2009 6
2010 1
2011 5
2012 2
2013 4
2014 3
2015 8
2016 10
2017 9
2018 13
2019 11
2020 10
2021 24
2022 31
2023 7

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
Madhi SA, Baillie V, Cutland CL, Voysey M, Koen AL, Fairlie L, Padayachee SD, Dheda K, Barnabas SL, Bhorat QE, Briner C, Kwatra G, Ahmed K, Aley P, Bhikha S, Bhiman JN, Bhorat AE, du Plessis J, Esmail A, Groenewald M, Horne E, Hwa SH, Jose A, Lambe T, Laubscher M, Malahleha M, Masenya M, Masilela M, McKenzie S, Molapo K, Moultrie A, Oelofse S, Patel F, Pillay S, Rhead S, Rodel H, Rossouw L, Taoushanis C, Tegally H, Thombrayil A, van Eck S, Wibmer CK, Durham NM, Kelly EJ, Villafana TL, Gilbert S, Pollard AJ, de Oliveira T, Moore PL, Sigal A, Izu A; NGS-SA Group; Wits-VIDA COVID Group. Madhi SA, et al. Among authors: moore pl. N Engl J Med. 2021 May 20;384(20):1885-1898. doi: 10.1056/NEJMoa2102214. Epub 2021 Mar 16. N Engl J Med. 2021. PMID: 33725432 Free PMC article. Clinical Trial.
T cell responses to SARS-CoV-2 spike cross-recognize Omicron.
Keeton R, Tincho MB, Ngomti A, Baguma R, Benede N, Suzuki A, Khan K, Cele S, Bernstein M, Karim F, Madzorera SV, Moyo-Gwete T, Mennen M, Skelem S, Adriaanse M, Mutithu D, Aremu O, Stek C, du Bruyn E, Van Der Mescht MA, de Beer Z, de Villiers TR, Bodenstein A, van den Berg G, Mendes A, Strydom A, Venter M, Giandhari J, Naidoo Y, Pillay S, Tegally H, Grifoni A, Weiskopf D, Sette A, Wilkinson RJ, de Oliveira T, Bekker LG, Gray G, Ueckermann V, Rossouw T, Boswell MT, Bhiman JN, Moore PL, Sigal A, Ntusi NAB, Burgers WA, Riou C. Keeton R, et al. Among authors: moore pl. Nature. 2022 Mar;603(7901):488-492. doi: 10.1038/s41586-022-04460-3. Epub 2022 Jan 31. Nature. 2022. PMID: 35102311 Free PMC article.
Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.
Cele S, Jackson L, Khoury DS, Khan K, Moyo-Gwete T, Tegally H, San JE, Cromer D, Scheepers C, Amoako DG, Karim F, Bernstein M, Lustig G, Archary D, Smith M, Ganga Y, Jule Z, Reedoy K, Hwa SH, Giandhari J, Blackburn JM, Gosnell BI, Abdool Karim SS, Hanekom W; NGS-SA; COMMIT-KZN Team; von Gottberg A, Bhiman JN, Lessells RJ, Moosa MS, Davenport MP, de Oliveira T, Moore PL, Sigal A. Cele S, et al. Among authors: moore pl. Nature. 2022 Feb;602(7898):654-656. doi: 10.1038/s41586-021-04387-1. Epub 2021 Dec 23. Nature. 2022. PMID: 35016196 Free PMC article.
Omicron infection enhances Delta antibody immunity in vaccinated persons.
Khan K, Karim F, Cele S, Reedoy K, San JE, Lustig G, Tegally H, Rosenberg Y, Bernstein M, Jule Z, Ganga Y, Ngcobo N, Mazibuko M, Mthabela N, Mhlane Z, Mbatha N, Miya Y, Giandhari J, Ramphal Y, Naidoo T, Sivro A, Samsunder N, Kharsany ABM, Amoako D, Bhiman JN, Manickchund N, Abdool Karim Q, Magula N, Abdool Karim SS, Gray G, Hanekom W, von Gottberg A; COMMIT-KZN Team; Milo R, Gosnell BI, Lessells RJ, Moore PL, de Oliveira T, Moosa MS, Sigal A. Khan K, et al. Among authors: moore pl. Nature. 2022 Jul;607(7918):356-359. doi: 10.1038/s41586-022-04830-x. Epub 2022 May 6. Nature. 2022. PMID: 35523247 Free PMC article.
SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape.
Cele S, Karim F, Lustig G, San JE, Hermanus T, Tegally H, Snyman J, Moyo-Gwete T, Wilkinson E, Bernstein M, Khan K, Hwa SH, Tilles SW, Singh L, Giandhari J, Mthabela N, Mazibuko M, Ganga Y, Gosnell BI, Karim SSA, Hanekom W, Van Voorhis WC, Ndung'u T; COMMIT-KZN Team; Lessells RJ, Moore PL, Moosa MS, de Oliveira T, Sigal A. Cele S, et al. Among authors: moore pl. Cell Host Microbe. 2022 Feb 9;30(2):154-162.e5. doi: 10.1016/j.chom.2022.01.005. Epub 2022 Jan 14. Cell Host Microbe. 2022. PMID: 35120605 Free PMC article.
Omicron - Decoupling Infection from Severe Disease.
Moore PL, Baden LR. Moore PL, et al. N Engl J Med. 2022 Apr 7;386(14):1361-1362. doi: 10.1056/NEJMe2201812. N Engl J Med. 2022. PMID: 35388673 Free PMC article. No abstract available.
Audio Interview: Dissecting the Host Response to SARS-CoV-2.
Rubin EJ, Baden LR, Moore PL, Morrissey S. Rubin EJ, et al. Among authors: moore pl. N Engl J Med. 2022 Jun 2;386(22):e69. doi: 10.1056/NEJMe2207246. N Engl J Med. 2022. PMID: 35648713 No abstract available.
The antibody response in HIV-1-infected donors.
Richardson SI, Moore PL. Richardson SI, et al. Among authors: moore pl. Curr Opin HIV AIDS. 2019 Jul;14(4):233-239. doi: 10.1097/COH.0000000000000559. Curr Opin HIV AIDS. 2019. PMID: 31033730 Free PMC article. Review.
Targeting Fc effector function in vaccine design.
Richardson SI, Moore PL. Richardson SI, et al. Among authors: moore pl. Expert Opin Ther Targets. 2021 Jun;25(6):467-477. doi: 10.1080/14728222.2021.1907343. Epub 2021 Apr 6. Expert Opin Ther Targets. 2021. PMID: 33754933 Review.
187 results